Paper3098544
Aldose reductase inhibitors and late complications of diabetes.
Benfield P. Drugs, 1986. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Aldose reductase inhibitors and late complications of diabetes. Papers, record 3098544. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3098544
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aldehyde Reductase | Major topic |
| Diabetic Neuropathies | Major topic |
| Diabetic Retinopathy | Major topic |
| Imidazoles | Major topic |
| Imidazolidines | Major topic |
| Sugar Alcohol Dehydrogenases | Major topic |
| Drug Hypersensitivity | |
| Humans | |
| Kinetics |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6427041 | Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil. | Diabetes | 1984 | https://conductscience.org/library/papers/6427041 | PubMed |
| 2 | 6243893 | Pathology of autonomic neuropathy in diabetes mellitus. | Ann Intern Med | 1980 | https://conductscience.org/library/papers/6243893 | PubMed |
| 3 | 6808090 | Inhibition of human brain aldose reductase and hexonate dehydrogenase by alrestatin and sorbinil. | J Neurochem | 1982 | https://conductscience.org/library/papers/6808090 | PubMed |
| 4 | 6404681 | The effect of an aldose reductase inhibitor (Sorbinil) on the level of metabolites in lenses of diabetic rats. | Diabetes | 1983 | https://conductscience.org/library/papers/6404681 | PubMed |
| 5 | 6225686 | A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy. | Diabetes | 1983 | https://conductscience.org/library/papers/6225686 | PubMed |
| 6 | 6401351 | Aldose reductase inhibition improves nerve conduction velocity in diabetic patients. | N Engl J Med | 1983 | https://conductscience.org/library/papers/6401351 | PubMed |
| 7 | 6432615 | Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathy. | Diabetologia | 1984 | https://conductscience.org/library/papers/6432615 | PubMed |
| 8 | 3927328 | Reversal of stage-I sugar cataract by Sorbinil, an aldose reductase inhibitor. | Pharmacology | 1985 | https://conductscience.org/library/papers/3927328 | PubMed |
| 9 | 6785131 | Clinical trial of an aldose reductase inhibitor in diabetic neuropathy. | Diabetes | 1981 | https://conductscience.org/library/papers/6785131 | PubMed |
| 10 | 4073075 | Complications of diabetes. Prevalence, detection, current treatment, and prognosis. | Am J Med | 1985 | https://conductscience.org/library/papers/4073075 | PubMed |
| 11 | 2863103 | Metabolic disposition and pharmacokinetics of the aldose reductase inhibitor tolrestat in rats, dogs, and monkeys. | Drug Metab Dispos | 1985 | https://conductscience.org/library/papers/2863103 | PubMed |
| 12 | 4064465 | Effect of tolrestat on red blood cell sorbitol levels in patients with diabetes. | Clin Pharmacol Ther | 1985 | https://conductscience.org/library/papers/4064465 | PubMed |
| 13 | 3032499 | Aldose reductase inhibition, glomerular metabolism, and diabetic nephropathy. | Diabet Med | 1985 | https://conductscience.org/library/papers/3032499 | PubMed |
| 14 | 6407887 | Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats. | Diabetologia | 1983 | https://conductscience.org/library/papers/6407887 | PubMed |
| 15 | 3920474 | Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat. | Metabolism | 1985 | https://conductscience.org/library/papers/3920474 | PubMed |
| 16 | 3921093 | Screening for treatable diabetic retinopathy. | Br Med J (Clin Res Ed) | 1985 | https://conductscience.org/library/papers/3921093 | PubMed |
| 17 | 3930330 | Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor: a 24-week controlled trial. | Diabetologia | 1985 | https://conductscience.org/library/papers/3930330 | PubMed |
| 18 | 7356219 | Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. | Ann Intern Med | 1980 | https://conductscience.org/library/papers/7356219 | PubMed |
| 19 | 3922829 | Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats. | Diabetologia | 1985 | https://conductscience.org/library/papers/3922829 | PubMed |
| 20 | 3080763 | Diminished proteinuria in diabetes mellitus by sorbinil, an aldose reductase inhibitor. | Pharmacology | 1986 | https://conductscience.org/library/papers/3080763 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37805545 | Novel role for epalrestat: protecting against NLRP3 inflammasome-driven NASH by targeting aldose reductase. | J Transl Med | 2023 | https://conductscience.org/library/papers/37805545 | PubMed |
| 28535208 | Sodium glucose cotransporter 2 in mesangial cells and retinal pericytes and its implications for diabetic nephropathy and retinopathy. | Glycobiology | 2017 | https://conductscience.org/library/papers/28535208 | PubMed |
| 18984854 | Proteomic changes associated with diabetes in the BB-DP rat. | Am J Physiol Endocrinol Metab | 2009 | https://conductscience.org/library/papers/18984854 | PubMed |
| 11716759 | myo-Inositol oxygenase: molecular cloning and expression of a unique enzyme that oxidizes myo-inositol and D-chiro-inositol. | Biochem J | 2001 | https://conductscience.org/library/papers/11716759 | PubMed |
| 2721987 | Sorbitol metabolism in retina studied in vitro. | Graefes Arch Clin Exp Ophthalmol | 1989 | https://conductscience.org/library/papers/2721987 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKR1A1 | 10327 | PubTator's text mining | https://conductscience.org/library/genes/10327 | NCBI Gene |
| AKR1B1 | 231 | PubTator's text mining | https://conductscience.org/library/genes/231 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3098544
GET https://conductscience.org/api/papers/v1/3098544/references?page=2